AtaiBeckley is being acquired by Eli Lilly at $6.75/share plus a $2.50 CVR—see the deal terms, milestone risks, and pipeline ...
Celcuity wins FDA approval for REVTORPYK in HR+/HER2- breast cancer; outlook tempered by phase 3 data, competition & launch ...
Get all latest & breaking news on Power Transmission . Watch videos, top stories and articles on Power Transmission at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results